太阳集团5493||欢迎登录

Be the most trusted biotech company

2018-01-22

Innovation-driven Development | Market Capitalization of Henlius Biotech Hits CNY 10 Billion
2016-12-13

Licensing Cooperation Between Fosun Pharma’s Monoclonal Antibody Platform Henlius and Korea’s AbClon
2016-10-31

Henlius Completed Phase I Clinical Study of Its New Drug for Breast Cancer
2016-10-17

Henlius Biosimilar Innovation Breakthrough